TheEdgeResearch
Home / Stocks / MSSTF

Mindset Pharma Inc. (MSSTF)

OTC Healthcare Biotechnology
$0.54 ▼ -0.37%
Market Cap
$54.5M
Sector
Healthcare
Industry
Biotechnology
Beta
-0.10
52-Wk Range
0.1626-0.559
CEO
James Andre-Charles Lanthier
Country
CA
Currency
USD

Mindset Pharma Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.54, down 0.37% on the session, giving a market capitalisation of $54.5M. On trailing twelve-month figures it carries a trailing P/E of -4.29, a net margin of -425.2%. Its beta of -0.10 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-4.29
Price / Sales
20.01
Price / Book
46.73
EV / EBITDA
-4.21
Gross margin
100.0%
Operating margin
-424.4%
Net margin
-425.2%
Return on equity
—
Debt / equity
0.12
Current ratio
1.18
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2021-02-08
Headquarters
Toronto, ON, CA
About Mindset Pharma Inc.

Headquartered in Toronto, Canada, Mindset Pharma Inc. is dedicated to the development and commercialization of psychedelic medications for the treatment of neurological and psychiatric conditions within Canada. A key component of their pipeline involves advancing MSP-1014, a specific psychedelic drug candidate.

Comparable companies

Mindset Pharma Inc. is most often compared with the following Healthcare names:

BSTGHITCHRPMFINNPFKDEVFMCIOFMVRBFNEVPFONPPFRLFTD
More research on MSSTF
MSSTF technical analysis MSSTF TheEdge Score Compare against peers
Open full interactive analysis & DCF →